Embracing a brave new world at the helm of Latin America's FIFARMA

1 September 2022
yaneth_giha_large

Yaneth Giha, the first woman to serve as executive director of FIFARMA, the Latin American Federation of the Pharmaceutical Industry, spoke to Angel Galindo, The Pharma Letter’s Latin America correspondent.

Dr Giha is a Colombian economist and well-versed in healthcare and industry in the country, where she served for more than three years as executive president of AFRIDO, the national trade association for the pharmaceutical sector. She was also Minister of Education and general director of Colciencias, the nation’s institute for scientific research.

“It’s an honor to be the first woman to lead FIFARMA and to be part of a group of people who work every day for better health systems in the region,” she said. “As a woman, I understand the challenge we have, to continue showing so many other women that we can achieve what we want, if we put action, love and discipline into everything we undertake. We are here to support more women and make gender equality an everyday task.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical